These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 29773272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
    Wu JQ, Lu MP, Reed AM.
    World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An update on inflammatory myositis in children.
    Huber A, Feldman BM.
    Curr Opin Rheumatol; 2013 Sep; 25(5):630-5. PubMed ID: 23912317
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
    Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ, Juvenile Dermatomyositis Research Group UK.
    Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
    [Abstract] [Full Text] [Related]

  • 7. Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes.
    Kim H, Huber AM, Kim S.
    Rheum Dis Clin North Am; 2021 Nov; 47(4):669-690. PubMed ID: 34635298
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis.
    Sag E, Demir S, Bilginer Y, Talim B, Haliloglu G, Topaloglu H, Ozen S.
    Semin Arthritis Rheum; 2021 Feb; 51(1):95-100. PubMed ID: 33360233
    [Abstract] [Full Text] [Related]

  • 12. Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
    Hinze CH, Oommen PT, Dressler F, Urban A, Weller-Heinemann F, Speth F, Lainka E, Brunner J, Fesq H, Foell D, Müller-Felber W, Neudorf U, Rietschel C, Schwarz T, Schara U, Haas JP.
    Pediatr Rheumatol Online J; 2018 Jun 25; 16(1):40. PubMed ID: 29940960
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH, Speth F, Oommen PT, Haas JP.
    Pediatr Rheumatol Online J; 2018 Jun 20; 16(1):38. PubMed ID: 29925381
    [Abstract] [Full Text] [Related]

  • 16. Juvenile dermatomyositis: novel treatment approaches and outcomes.
    Varnier GC, Pilkington CA, Wedderburn LR.
    Curr Opin Rheumatol; 2018 Nov 20; 30(6):650-654. PubMed ID: 30124602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biologics in refractory idiopathic inflammatory myositis (IIM): What experience in juvenile vs adult myositis tells us about the use of biologics in pediatric IIM.
    Patwardhan A, Spencer CH.
    Mod Rheumatol; 2021 Sep 20; 31(5):933-948. PubMed ID: 33499694
    [Abstract] [Full Text] [Related]

  • 20. Developing a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.
    McCann LJ, Arnold K, Pilkington CA, Huber AM, Ravelli A, Beard L, Beresford MW, Wedderburn LR.
    Pediatr Rheumatol Online J; 2014 Sep 20; 12():31. PubMed ID: 25075205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.